跳至主要内容
临床试验/IRCT20200112046094N2
IRCT20200112046094N2招募中3 期

Ticagrelor plus Aspirin vs Clopidogrel plus Aspirin in MInor Non-cardioembolic Ischemic Stroke (TACAMINIS)

Mazandaran University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 no limit(—)
性别
All

入选标准

  • signing inform consent
  • recent ischemic stroke within 24 h, diagnosed by brain CT or MRI
  • mild stroke with NIHSS =<8
  • high risk TIA with ABCD >4
  • no cardioembolic source such as low E/F, MS, AF ,...
  • no specific etiology such as dissection, vasculitis, ...
  • no carotid stenosis > 50 % in side of involvement

排除标准

  • history of hypersensitivity to consumptive drug
  • any indication for anticoagulant therapy
  • acute phase treatment with intravenous thrombolysis or thrombectomy
  • any contraindication for consumptive drug
  • history of intracranial hemorrhage
  • history of GI bleeding during past 6 m
  • candidate for endarterectomy
  • history of coagulopathy
  • active hemorrhagic diatesis during randomization

研究者

相似试验